Abstract:AIM: To investigate integrin beta 3 mRNA and vascular endothelial growth factor (VEGF) protein expression in gastric carcinoma, and its correlation with microvascular density, growth-pattern, invasion, metastasis and prognosis.METHODS: In situ hybridization (ISH) of integrin beta 3 mRNA and immunohistochemistry of VEGF and CD34 protein were performed on samples from 118 patients with gastric cancer.RESULTS: The positive rate of integrin beta 3 mRNA in non-tumor gastric mucosa (20%) was significantly lower than that of the gastric cancer tissue (52.5%, X-2 = 10.20, P < 0.01). In patients of infiltrating type, stage T-3-T-4, vessel invasion, lymphatic metastasis, hepatic or peritoneal metastasis, the positive expression rates of integrin beta 3 mRNA were significantly higher than those in patients of expanding type (P < 0.01), stage T-1-T-2 (P < 0.01), non-vessel invasion (P < 0.01), without lymphatic metastasis (P < 0.01), without hepatic and peritoneal metastasis (P < 0.01), respectively. In patients of infiltrating type, stage T-3-T-4, vessel invasion, lymphatic metastasis, hepatic or peritoneal metastasis, the positive expression rates of VEGF protein. were significantly higher than those in patients of expanding type (P < 0.01), stage T-1-T-2 (P < 0.01), non-vessel invasion (P < 0.01), without lymphatic metastasis (P < 0.01), without hepatic and peritoneal metastasis (P < 0.01), respectively. In patients of infiltrating type, stage T-3-T-4, vessel invasion, lymphatic metastasis, hepatic or peritoneal metastasis, the mean MVD were significantly higher than those in patients of expanding type (P < 0.01), stage T-1-T-2 (P < 0.01), non-vessel invasion (P < 0.01), without lymphatic metastasis (P < 0.01), without hepatic and peritoneal metastasis (P < 0.01), respectively. It was found that the positive expression rate of integrin beta 3 mRNA was positively related to that of VEGF protein (P < 0.01) and MVD (P < 0.05), meanwhile the positive expression rate of VEGF protein was positively related to MVD (P < 0.05); The mean survival period in patients with positive expression of integrin beta 3 mRNA and VEGF, and MVD >= 54.9/mm(2) was significantly shorter than that in patients with negative expression of integrin beta 3 mRNA (P < 0.05) and VEGF (P < 0.01), and MVD < 54.9/mm(2) (P < 0.01). Five-year survival rate in patients with positive expression of integrin beta 3 mRNA and VEGF, and MVD >= 54.9/mm(2) was significantly lower than those with negative expression of integrin beta 3 mRNA (P < 0.05), VEGF (P < 0.05), and MVD < 54.9/mm(2) (P < 0.01).CONCLUSION: Integrin beta 3 and VEGF expression can synergistically enhance tumor angiogenesis, and may play a crucial role in invasion and metastasis of gastric carcinoma. Therefore, they may be prognostic biomarkers and novel molecular therapeutic targets. (c) 2008 WJG. All rights reserved.

Prognostic Value of Vascular Endothelial Growth Factor Receptor 1 and Class III Β-Tubulin in Survival for Non-Metastatic Rectal Cancer

Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

[Relationship Between the Protein Expression of P53, C-Erbb-2, Vascular Endothelial Growth Factor and CD44 and the Survival Rates of Stage II( Colorectal Cancer Patients Without Radiochemotherapy after Radical Resection].

Expression and Clinical Significance of Vascular Endothelial Growth Factor and Fms-Related Tyrosine Kinase 1 in Colorectal Cancer.

Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.

Prognostic Significance of Vascular Endothelial Growth Factor Protein Levels in T1-2 N0 Laryngeal Cancer Treated with Primary Radiation Therapy

Correlation of Integrin Β3 Mrna and Vascular Endothelial Growth Factor Protein Expression Profiles with the Clinicopathological Features and Prognosis of Gastric Carcinoma

Prognostic Value of Vascular Endothelial Growth Factor Expression in Resected Gastric Cancer.

Clinical significance of VEGF-C expression and LVD detection in predicting the prognosis of stage Ⅱ postoperative colorectal cancer

Expression of Vascular Endothelial Growth Factor and Its Kinase Insert Domain Containing Receptor in Colorectal Cancer Tissue and Its Relation with the Prognosis of Colorectal Carcinoma

Expression of HIF-1alpha and VEGF in Colorectal Cancer: Association with Clinical Outcomes and Prognostic Implications.

Study on Expression of Transforming Growth Factor Β1 in Human Colorectal Carcinoma and Its Correlation with Prognosis

The expression of VEGF-D and prognosis of patients with colorectal carcinoma

Expression of Vascular Endothelial Growth Factor Can Predict Distant Metastasis and Disease-Free Survival for Clinical Stage III Rectal Cancer Following 30-Gy/10-f Preoperative Radiotherapy.

[Expression of molecular markers detected by immunohistochemistry and risk of lymph node metastasis in stage T1 and T2 colorecrectal cancers]

Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma.

Correlation of the Expression of VEGF-C with CEA and Survivin and Their Correlation in Rectal Cancer

VEGFR-2 As a Novel Predictor of Survival in Gastric Cancer: A Systematic Review and Meta-Analysis

Expression of VEGFR2 and NRP-1 in Non-Small Cell Lung Cancer and Their Clinical Significance

Prognostic Significance of C-Erbb-2 and Vascular Endothelial Growth Factor in Colorectal Liver Metastases

Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I non-small cell lung cancer.